Home » Reports » Broker Ratings » GlaxoSmithKline plc 2.5% Potential Decrease Indicated by Bryan Garnier

GlaxoSmithKline plc 2.5% Potential Decrease Indicated by Bryan Garnier

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ this morning by analysts at Bryan Garnier. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Bryan Garnier have set a target price of 1773 GBX on its stock. This would indicate that the analyst believes there is a downside of -2.5% from today’s opening price of 1818 GBX. Over the last 30 and 90 trading days the company share price has increased 55.6 points and increased 96.4 points respectively. The 1 year high stock price is 1857 GBX while the 52 week low is 1472.8 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,797.44 GBX and a 200 day moving average of 1,696.83. There are currently 4,990,552,666 shares in issue with the average daily volume traded being 7,702,000. Market capitalisation for LON:GSK is £90,380,504,880 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn